Mitochondria densely populate cells in central nervous system providing essential energy for neurons and influencing synaptic plasticity. Harm to these organelles can impair cognitive performance through damaged neurotransmission and altered Ca 2+ homeostasis. Impaired cognition could be one underlying factor which can characterize major depressive disorder, a huge burden for society marked by depressed mood and anhedonia. 
Introduction
Mitochondria were described in the mid-1800s by Kölliker, however, their function was better characterized a century later by delineating their role in energy production including β-oxidation, Krebs cycle, and oxidative phosphorylation (oxphos) (Liesa et al., 2009 ). Mitochondria contain their own genome (mitochondrial DNA, mtDNA) to encode for 13 necessary proteins of the electron transport chain and cover 92% of the body's energy demand through oxphos (Boekema and Braun, 2007 , Wallace et al., 2010 , Bansal and Kuhad, 2016 . The brain is especially dependent on mitochondrial energy, since it only stores small amounts of glycogen and, thus, its energy reserves are highly limited. As a by-product of energy production, reactive oxygen species are formed, however, mitochondria also contribute to the defense against these free radicals producing protective factors (Bansal and Kuhad, 2016 , Adam-Vizi and Tretter, 2013 , Sinha et al., 2013 . Another important feature of mitochondria is their involvement in programmed cell death, apoptosis. Mitochondria can be involved in both extrinsic and intrinsic apoptotic pathways, the latter being more common in neurons (Kam and Ferch, 2000, Wyllie, 2010) . It also became evident that, though sometimes truly round shaped organelles, mitochondria can form connected tubules and their shape is regulated through fusion and fission and disturbances of this dynamism can lead to severe genetic diseases, e.g. Charcot-Marie-Tooth disease type 2A (Bereiter-Hahn and Voth, 1994 , Zuchner et al., 2004 , Chan, 2006 .
The above discussed functions make mitochondria indispensable in network processes such as cognition. It has been demonstrated in mice that intact mitochondrial functions are required for proper synaptic plasticity (Weeber et al., 2002 , Levy et al., 2003 , Picard and McEwen, 2014 . Mitochondria accumulate Ca 2+ -ions in their matrices and participate in intracellular signaling processes involving Ca 2+ -dependent mechanisms. One of these processes is NMDA-receptor mediated long-term potentiation, serving as the cellular model for memory functions and higher order cognitive processes (Giacomello et al., 2007 , Mattson et al., 2008 , Herring and Nicoll, 2016 . However, other mechanisms may also play a role.
Apoptosis, while especially important during development (Roth and D'Sa, 2001 ), contributes to the normal physiology of the adult brain, too. For example, during learning in Morris water maze, an animal model for spatial learning and memory, adult-born dentate granule cells may be removed through apoptosis, if they prove to be functionally unnecessary in networks (Deng et al., 2010) . In addition, studies suggested impaired mitochondrial functions in different neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, Huntington disease and amyotrophic lateral sclerosis, where cognitive functions are fundamentally impaired contributing to one of the leading symptoms of these diseases [for a review see (Golpich et al., 2017) ].
In addition to the already discussed cognitive dysfunctions, alterations in mitochondria-mediated mechanisms seem to contribute to depression, similarly considered a network level disease (Castren, 2005 , Bansal and Kuhad, 2016 , Morava and Kozicz, 2013 , Tobe, 2013 , Filipovic et al., 2017a , Shimamoto and Rappeneau, 2017 . Major depressive disorder (MDD) is a high burden for society characterized by anhedonia and depressed mood and often also accompanied by cognitive disturbances. Previous studies found that depression was the initial symptom of mitochondrial diseases (Fattal et al., 2007) , mutations of mitochondrial or mitochondria-related nuclear genes associated with major depression (Onishi et al., 1997 , Koene et al., 2009 , and mitochondrial disorder showed co-morbidity with depression (Morava et al., 2010) . Vice versa, mitochondrial mutations were also demonstrated in unipolar depression patients (Munakata et al., 2007 , Ben-Shachar and Karry, 2008 , Shao et al., 2008 . From a cognitive angle, although mood symptoms were considered predominant in depression, and were the main focus of both diagnosis and treatment in these disorders, recently, cognitive symptoms and impairment in mood disorders attracted increased attention and has been gaining wider recognition. It is important, however, that the role of most candidate genes in depression is thought to depend on stress exposure and/or traits and temperaments (Bagdy et al., 2012 , Gonda et al., 2009 , Sharma et al., 2016 . Interestingly, the combination of genes associated with cognition and others associated with traits or temperaments also have emerged in gene-gene interactions (Lazary et al., 2009 , Lazary et al., 2011 . Cognitive dysfunction symptoms in major depression include attention, memory and executive function deficits contributing to decreased capacity for planning and decision (Hammar and Ardal, 2009) . Besides significantly effecting function during acute depressive episodes, with treatment approaches focusing on mood symptoms, cognitive deficits often persist as residual symptoms after restoring mood and contribute to lack of complete functional recovery impairing social, academic and professional function on the long-term, significantly decreased quality of life, and increased risk of relapse (Beats et al., 1996 , Castaneda et al., 2008 , Hammar and Ardal, 2009 , Marazziti et al., 2010 . Cognitive symptoms have been found to be present during 80-90% of depressive episode length and also 40-45% of the length of remission phases and executive function, verbal learning and memory deficits can also be identified during euthymic periods emphasizing their involvement in the pathophysiology of the disease and their importance in treatment (Biringer et al., 2005 , Smith et al., 2006 , Conradi et al., 2011 .
While depression and accompanying cognitive impairment may not be exclusively of mitochondrial origin, substantial damage to mitochondrial functions can contribute to both of them. Thus, alterations in mitochondrial proteins (encoded either in nuclear genes or the mitochondrial genome) attenuating the functions and capabilities of these organelles can lead to a depressive phenotype which may be characterized by altered cognitive functions. The present review highlights some genes from mtDNA and from nuclear DNA involved in primary (TOMM40 and MTHFD1L) and secondary mitochondrial dysfunctions (ATP6V1B2 and MAO) linking mitochondria with diminished cognitive performance and major depression to argue for endophenotypes in the disease and provide testable biomarkers for further studies.
Mitochondrial DNA
The human mtDNA encodes 2 ribosomal RNAs, 22 transfer RNAs and 13 proteins of the electron transport chain, organized in nucleoids with only a few noncoding bases between the genes (Anderson et al., 1981, Morava and Kozicz, 2013) . MtDNA is always maternally inherited and no recombination occurs (Byrne et al., 2009) . Consequently, mutations in mtDNA are in linkage disequilibrium with all other variants. Thus, characterized by a given set of variants nine major haplogroups evolved and are present currently in the European population (Byrne et al., 2009) . MtDNA is prone to mutations, one individual of every 200 is a pathogenic mutation carrier, but usually without symptoms (Cree et al., 2009) . In normal tissues all mtDNA in a given cell is identical, referred to as homoplasmy. If mutations are present, a smaller or larger subset of the mitochondria will contain them, thus, cells will have both wild-type and mutant mitochondria, called heteroplasmy (DiMauro and Schon, 2008) .
Usually a certain "mutation load", a certain degree of heteroplasmy of the cells is required to produce phenotypic symptoms and threshold for disease manifestation is high, around 80-90%. The reason for such a high threshold may be that mitochondria can counteract deleterious mutations. Different pathogenic mtDNA-mutation carrying cells, after hybridization were able to restore respiratory activity suggesting that fusion of mitochondria with polymorphisms at different sites could compensate for the original defects (Ono et al., 2001 , Chan, 2006 ).
An impact of mitochondrial genetic variations on cognitive functions in mice was demonstrated by Sharpley et al. (Sharpley et al., 2012) . Interestingly, animals with heteroplasmy from two "normal" mitochondrial genome differing by 91 nucleotides performed worse in the Barnes cognitive maze test than any of the homoplasmy group (Sharpley et al., 2012) . In contrast, in elderly adults' rate of heteroplasmy at certain candidate mutation sites in the complex I of the respiratory chain showed associations with decreased cognitive performance in the Modified Mini-Mental State Examination (Tranah et al., 2015) . MtDNA mutations in depression were also demonstrated. A deletion in mtDNA in a child was associated with mitochondrial disease symptoms and also with mild-moderate unipolar depression (Koene et al., 2009 ). Using post-mortem brain samples from human subjects none of the mitochondrial haplogroups was associated with schizophrenia, bipolar disorder or major depression (Sequeira et al., 2015) . Major depression cases, however, showed rare homoplasmic mutations with possible functional consequences in the ATP synthase 8 (ATP8), ATP synthase 6 (ATP6), ND5 and cytochrome b (CYTB) genes, while another subject with depression demonstrated subthreshold heteroplasmy rate at a variant in the displacement loop (D-loop) part of mtDNA (Sequeira et al., 2015) ..
In summary, mutations in mtDNA may influence cognitive performance and depression. However, common mutations or rare ones below a certain threshold were usually unable to show compelling evidence for association with the phenotypes (though small sample sizes may also play a role). In contrast, these mutations were deleterious and caused severe diseases above a certain threshold, with significantly attenuated cognitive performance and mood disorders, but also fatigue and other mitochondria associated symptoms. This allor-nothing type of response can be a result of the compensatory capacities of these organelles.
But mitochondria also rely on nuclear genes to maintain their normal capacities, like respiratory chain functions, translation, transcription and protein maintenance (DiMauro and Schon, 2008, Morava and Kozicz, 2013) . Polymorphisms within these nuclear genes, (which are usually of small effect size, at least, in depression) may have smaller, but less compensable effects and can be responsible for different phenotypes, like mild cognitive impairments (Mastroeni et al., 2016) .
TOMM40
The translocase of outer membrane (TOM) complex imports most of the pre-proteins into mitochondria (Larsen et al., 2017) . TOM40, one of the seven subunits of the TOM complex, is the central pore of the mitochondrial protein import apparatus (Gottschalk et al., 2014) . It has an essential role in the life of most eukaryotic organisms, and studies suggest that reducing TOM40 levels causes mithochondrial dysfunction (Gottschalk et al., 2014) .
The translocase of outer mithochondrial membrane 40 (TOMM40) gene is located on chromosome 19 in the tight gene cluster TOMM40-APOE-APOC1-APOC4-APOC2 with strong linkage disequilibrium (Gottschalk et al., 2014) . Apolipoprotein E (APOE) gene's ε4
allele is a well-known genetic risk factor for the development of Alzheimer's disease (Corder et al., 1993 , Farrer et al., 1997 , Gibson et al., 2000 ; and is also associated with the onset (Butters et al., 2003) and severity of late-life depression (Yen et al., 2007) . TOMM40 is located only 15 kb upstream to APOE (Zeh, 2013) , and GWASs also suggested association between TOMM40 and Alzheimer's disease (Grupe et al., 2007 , Harold et al., 2009 , Naj et al., 2010 , Seshadri et al., 2010 , but studies about its independent role in Alzheimer's disease and depression are scarce (McFarquhar et al., 2014) .
Some studies showed a connection between TOMM40 and risk of late-onset Alzheimer's disease, cognitive performance and hippocampal atrophy independently of APOE (Gottschalk et al., 2014) ; while others couldn't detect an APOE-independent effect of TOMM40 on Alzheimer's disease risk (Zeh, 2013 , Gottschalk et al., 2014 . The mixed results could be partly explained by technical and methodological differences between approaches of different researcher groups and the data collectively suggest the contribution of TOMM40 to Alzheimer's disease and related phenotypes (Gottschalk et al., 2014) .
A study (McFarquhar et al., 2014) identified an association between TOMM40 rs2075650 and history of major depression. Risk allele carriers with lifetime or current depression showed decreased level of extraversion; and the risk allele was also associated with cognitive deficits (mild executive dysfunction, decrease in positive memory intrusions) during current depression, and with altered neuronal processing of sad faces in the cingulate cortex (independently of depression). The researchers suggested that TOMM40 risk allele carriers have altered cingulate cortex functions, which could interact with depression.
In a study of knock-down mice (Zeh, 2013) it was found that the TOMM40 +/-mice had decreased numbers of dopaminergic neurons at the age of two compared to their normal littermates. This result might relate to the association between TOMM40 and depression through the well-known dopaminergic dysfunction in depression (Dunlop and Nemeroff, 2007 ).
An interesting novel theory could add some important information to this topic. The
Alu neurodegeneration hypothesis (Larsen et al., 2017) postulates an age-related genetic mechanism contributing to mitochondrial dysfunction, eventually leading to neuronal death.
Alu elements are primate-specific retrotransposons within TOMM40 with supposed fundamental role in primate evolution, and possibly underlying the origin of higher brain functions. The authors highlight that enhanced somatic retrotransposon activity in neurologic networks correlates with tissue-specific mitochondrial dysfunction which increases with time and/or epigenetic changes, and thus, contributes to neurodegenerative diseases. Through this mechanism, depression may be the first symptom of later life cognitive decline, with the first mild signs possibly measurable by neurocognitive tasks.
Further investigations are needed to better understand the relationship between TOMM40, cognitive deficits and depression, but it seems plausible that alterations of TOMM40 may play a role in the disorders and mitochondrial functions.
MTHFD1L
As a member of the folate-mediated one-carbon metabolism, human mitochondrial monofunctional 10-formyl-tetrahydrofolate synthetase (C 1 -THF synthase or MTHFD1L)
enzyme is tightly associated with the matrix side of mitochondrial inner membrane (Prasannan and Appling, 2009) , catalyzing the conversion of 10-formyl-tetrahydrofolate into formate, both in embryonic (Pike et al, 2010) and adult (Prasannan and Appling, 2009) mammalian mitochondria. Formate then fluxes out to get incorporated into the cytoplasmic branch of the folate-dependent one-carbon metabolism, being thus indispensable in cytoplasmic processes such as purine biosynthesis, thymidylate biosynthesis, and the methyl cycle (Pike et al, 2010 ).
In addition, MTHFD1L enzyme has been proven to be important in maintaining
proper mitochondrial function, since its knockdown reduces both basal oxygen consumption and electron transport chain capacity (Lee et al, 2017) .
The MTHFD1L gene encoding the MTHFD1L enzyme has a single nucleotide polymorphism (SNP), rs11754661, the A allele of which has been identified in a GWAS as a risk for Alzheimer's disease, and its significance survived the correction for genome-wide multiple testing (Naj et al., 2010) . This association between rs11754661 A allele and Alzheimer's disease was replicated in two further studies (Ren et al., 2011 , Ma et al., 2012 , but not in another (Ramirez-Lorca et al., 2011) .
The A allele of MTHFD1L rs11754661 has also been associated with depressive rumination (Eszlari et al., 2016) . Rumination denotes a cognitive response style to stress: a process of thinking repetitively and passively about the person's own distress, depressed mood and its possible causes and consequences, remaining fixated on his or her feelings and concerns without any active problem solving (Nolen-Hoeksema et al., 2008) . Thus, rumination is a cognitive risk factor for depression (Nolen-Hoeksema et al., 2008) . The A allele of the MTHFD1L rs11754661 polymorphism is associated with higher levels of both rumination and current depressive symptoms, and a higher lifetime risk for depression;
however, an asymmetry can be detected when taking into account the mediative effect of one on the other. Namely, the association of rs11754661 and depression is entirely mediated by rumination (Eszlari et al., 2016) . Consequently, it can be assumed that this polymorphism of the MTHFD1L gene by increasing rumination may be relevant in the development of other disorders related to rumination (Nolen-Hoeksema et al., 2008) .
Furthermore, the A allele of rs11754661 has been associated with high homocysteine (Hcy) levels (Wernimont et al., 2011) . Hcy is a non-protein amino acid with manifold harmful effects. Its high level is associated with major depression, reduced hippocampal volume, and in healthy subjects impaired cognitive functions (Moustafa et al., 2014) . Hcy exerts its harmful effects via multiple mechanisms, one of which is toxicity to mitochondria (Moustafa et al., 2014 , Du et al., 2016 . Furthermore, Hcy is part of the cytoplasmic branch of the folatedependent one-carbon metabolism (Pike et al, 2010) . In the cytoplasm, catabolism of Hcy is dependent on folate (Pike et al., 2010) and folic acid supplementation can effectively reduce Hcy levels (Moustafa et al., 2014 , Du et al., 2016 .
Future testing is required to determine whether the psychological and neuropsychiatric effects of this MTHFD1L polymorphism are truly mediated by current Hcy levels.
Nevertheless, MTHFD1L gene and the encoded mitochondrial protein MTHFD1L seems to be a promising target in the background of cognitive domains of depression.
ATP6V1B2
Another possible candidate linking mitochondria, cognition and depression is the ATPase H+ transporting V1 subunit B2 (ATP6V1B2) nuclear gene. The A allele of rs1106634, an intronic SNP in the ATP6V1B2 gene, which encodes the B subunit of the vacuolar ATP-ase, has been implicated with a suggestive significance in a meta-analysis of 3 genome-wide association studies (GWASs) in major depression (Shyn et al., 2011) , while its T allele was implicated in a genome-wide meta-analysis in bipolar disorder and schizophrenia (Wang et al., 2010) .
Although specific effects of ATP6V1B2 rs1106634 in depression or cognition were not described before, knowledge is accumulating on the role of this protein with its possible involvement in neurotransmission. The B subunit in the ATP-catalytic site of the vacuolar proton pump ATP-ase is located in the V1 cytosolic domain in a transmembrane complex and plays a role in creating a proton gradient across membranes of synaptic vesicles, mediating acidification of eukaryotic organelles including endosomes and lysosomes, thus, playing a role in receptor-mediated endocytosis, protein sorting, as well as synaptic vesicle protongradient generation (Shyn and Hamilton, 2010) . It may play a role in neurotransmission, as the protonmotive force created by vacuolar ATP-ases is involved in vesicle transport, reuptake and storage, and vacuolar ATP-ases also play a role in retrieval and reemployment of synaptic vesicles and energization of regenerated vesicles (Nelson, 1991 , van Hille et al., 1994 . Thus, even a small disruption in the electrochemical proton gradient may alter neurotransmitter release (Egashira et al., 2015) . Vacuolar ATP-ase, thought to be a redox sensor and its function regulated by cellular redox status, may also impact risk of depression through its involvement in oxidative stress (Wang and Floor, 1998 ). An association between a chromosome region containing ATP6V1B2 genes and myeloperoxidase levels reflecting prooxidative stress in a GWAS may support these assumptions (Reiner et al., 2013) . Vacuolar ATP-ase also plays a role in maintaining developing cortical neural stem cells in mouse models (Lange et al., 2011) .
Recently, a study on a large general population sample found evidence of an association between rs1106634 A allele and lifetime depression risk and also between this allele and worse neurocognitive performance on the paired associated learning test but not on the Stockings of Cambridge test. These results suggest that this gene has an effect on hippocampal but not on frontal dysfunction (Gonda et al., 2016) , and propose a novel molecular mechanism in the long-term risk for development of depression and possibly also its cognitive symptoms. To emphasize the role of this variant in cognitive dysfunction, previously a study reported increased ATP6V1B2 expression at both mRNA and protein levels in fibroblasts carrying a presenilin1 mutation, which is one of the major causes hypothesized in familiar Alzheimer's disease (Coffey et al., 2014) .
Mitochondria may be involved in the manifestation of the effects of ATP6V1B2 in depression and in cognitive symptoms of depression in several ways. Increased reactive oxygen species formation and decreased ATP production impair mitochondria (Bansal and Kuhad, 2016) . Furthermore, ATP6V1B2 was found to be expressed also in mitochondria (Jeon et al., 2011) . MtDNA depletion was associated with a wide range of human illnesses and dysfunctional cellular states, with cells remodeling mitochondrial functions and altering mitochondrial protein composition (Jeon et al., 2011) . During such states ATP6V1B2 was reported to be upregulated, leading to downregulation of ATP synthesis (Jeon et al., 2011) .
Impaired mitochondrial function disrupting energy homeostasis and causing reduced ATP availability may play a crucial role in depressive symptoms especially cognitive dysfunction, lack of energy and fatigue (Karabatsiakis et al., 2014) . In a study investigating mitochondrial respiration, significantly impaired mitochondrial function was reported including lower efficiency of coupling of respiration related to ATP turnover, and significant negative correlation between mitochondrial respiration and severity of depression symptoms including concentration difficulties, energy loss and fatigue suggesting a role for mitochondrial dysfunction in the pathophysiology of depression (Karabatsiakis et al., 2014) .
Furthermore, mitochondria are the chief reactive oxygen species producer and disturbance of oxidative homeostasis and oxidative stress is known to play a role in depression and neurocognitive dysfunction as well (Karabatsiakis et al., 2014) . Reactive oxygen species also have an adverse effect on mitochondrial DNA leading to accumulating lesions and, thus, impairing ATP production or respiratory chain function (Maes, 2011) .
Mitochondrial dysfunctions including increased mtDNA defects, decreased ATP production and enzyme activities show a significant association with depression (Gardner et al., 2003) .
Given the role of vacuolar ATP-ases as redox sensors and their function being influenced by cellular redox status, this may be a further pathway where the function of ATP6V1B2 and mitochondria converge.
MAO genes
Monoamine oxidase genes encode the mitochondrial isoenzymes monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B) and intracellularly both are located in the outer mitochondrial membrane (Squires, 1997) . These isoenzymes vary in location and selectivity in the human body. MAO-A is more likely distributed in fibroblast cells and placenta while MAO-B can be found in platelets and lymphocytes. They are also located in the brain (Bond and Cundall, 1977 , Donnelly and Murphy, 1977 , Naoi et al., 2017 . From the mitochondrial perspective, oxidative stress, through the production of hydrogen peroxide, which is partially the result of MAO enzyme activity, can cause mitochondrial damage (Edmondson, 2014 , Sorato et al., 2014 . In addition, MAO enzymes have important roles in catabolizing monoamines serotonin, dopamine, noradrenaline, and adrenaline, as well as diverse trace amines, while they also play a role in degradation of different xenobiotics through oxidative deamination (Edmondson et al., 2009, Bortolato and Shih, 2011) . MAO-A catalyzes degradation of monoamines, especially serotonin, playing a crucial role in mental disorders including unipolar depression and anxiety disorders (Bagdy et al., 1986 , Heninger et al., 1996 , Gingrich et al., 2003 , underlining the importance of MAO-A enzymes in mental health and pathology. To assess MAO-B functions in the context of depression, cognitive dysfunction and the mitochondria itself, it is important to say that both isoenzymes are working in a dichotomous way and prefer to degrade their specific monoamines. Nonetheless, MAO-A and MAO-B can compensate each other supporting the claim that there is nothing like an absolute specificity (Chen et al., 2004) . While MAO-A shows more direct relationship towards depression (Kersting et al., 2007) , MAO-B tends to affect emotional regulation, cognitive dysfunction, and disorders like Alzheimer's or Parkinson's disease, autism spectrum disorders (Dlugos et al., 2009 , Chakraborti et al., 2016 , attention-deficit hyperactive disorder (ADHD) (Li et al., 2008) and others. These results link both enzymes to depression and cognitive performance. (Sabol et al., 1998 , Gutierrez et al., 2004 . The first three were associated with psychiatric disorders (Bortolato and Shih, 2011), the last was reported to affect sleep quality and symptoms of depression (Brummett et al., 2007) , although contradictory results were also published failing to demonstrate a relationship between MAO-A-uVNTR and major depression or bipolar disorder (Syagailo et al., 2001) . MAO-A-uVNTR has been suggested to participate in cognitive disturbances in one study, although results did not survive correction for multiple testing (Yu et al., 2005) .
Additionally, the presence of CC genotype at the SNP, rs1137070, in the MAO-A gene predicted prolonged reaction time between infancy and childhood in girls. This attention deficit may be an effect of the altered availability of monoamine substances, including dopamine and serotonin that are also needed for brain development (Lundwall and Rasmussen, 2016) . In addition, a MAO-A functional mutation was identified in a family with intellectual and behavioral disorders suggesting a role for this enzyme in cognitive functions (Piton et al., 2014) . Furthermore, efficiency of the reversible MAO-A inhibitor moclobemide in elderly patients with dementia and depression also raise the idea that cognitive dysfunction and depression correlate with MAO-A functions (Amrein et al., 1999) .
In case of MAO-B, polymorphisms rs10521432 and rs6651806 associated with negative emotional behavior, while rs10521432 and rs66518806 seemed to influence cognitive performance (Dlugos et al., 2009) . Three other SNPs could be related to ADHD (Li et al., 2008) , while the disease itself showed elevated co-occurrence in bipolar and unipolar depressive patients compared to healthy controls (Harmanci et al., 2016) .
In summary, MAO overfunction appears to impair mitochondria through oxidative stress, while different polymorphisms may influence different facets of cognitive performance and mood disorders suggesting that MAO-A and MAO-B polymorphisms provide another link between mitochondria, mood and cognition.
Concluding remarks
Our present review focusing on mutations linking mitochondria, cognitive performance and depression, suggest various ways in which genes affecting mitochondrial functions can contribute to depression and attenuated cognitive performance. In this regard there may be differences between mtDNA polymorphisms, which could remain compensated for a long time through mitochondrial fusion, and nuclear ones, which can have smaller, but constant effects. The different combination of such loads in an individual can result in specific depressive and cognitive symptoms, but can also lead to an underlying risk for the disease with impairments mild enough to remain unnoticed. Such minor defects can be provoked by environmental stress, as suggested by Morava et al. (Morava and Kozicz, 2013) , where the authors hypothesized that stress may evoke otherwise unnoticeable mitochondrial dysfunctions (probably caused by different genetic mutations) present in the individual, explaining for the distinct resilience and coping capacities characterizing each person (Morava and Kozicz, 2013) . Indeed, we also argued previously that in addition to inherited or acquired genetic factors, environmental factors also contribute to depression, and their effects are mediated by genetic polymorphisms (Bagdy et al., 2012) . Development of depression is typically and strongly connected to environmental factors like childhood adversity and/or recent negative live events. Genetic factors show weak direct effects (Mbarek et al., 2017 , Xie et al., 2017 and in general they become apparent in the stress exposed groups or in gene-environment interactions , Kovacs et al., 2016a , 2016b , Bagdy et al., 2012 ). The risk genes described in this review belong to a set of genetic factors, where cognitive dysfunction is associated with the risk genes directly, but subsequent stress exposure may further sophisticate symptoms (Fig. 1) . The presented evidences suggest that nuclear genes in combination with mitochondrial ones may shape together such endophenotypes (Fig 1.) . Mitochondria-related nuclear polymorphisms associated with both depression and cognition, some even at a genome-wide level, support our assumptions, indicating that whatever the rate of contribution of mitochondrial mutations, if mitochondrial processes are affected, cognitive symptoms are more prominent in depression. Still, these cognitive symptoms in mood disorders remain often overlooked, despite the fact that they impose a serious burden on patients significantly compromising quality of life and impairing daily function in all domains. 
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